RecruitingHodgkin LymphomaNon-Hodgkin Lymphoma

Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors

Eligible age

18+ yrs

Accepts

All genders

Locations

31 states

Healthy volunteers

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

This study examines the impact of social and genetic factors on outcomes in adolescent and young adult (AYA) cancer survivors of Hodgkin or non-Hodgkin lymphoma. Compared to both older adult and childhood cancer patients, AYAs with cancer experience different diagnoses and specific biological, clinical, psychological and social factors that affect their risks for post-treatment morbidity and premature death. Collecting samples of blood samples and health and treatment information from cancer survivors of Hodgkin or non-Hodgkin lymphoma may help doctors identify conditions that increase the likelihood of AYAs getting sick and dying after treatment of cancer and better understand how to address the needs of adolescent and young adult cancer survivors.

Sponsor: ECOG-ACRIN Cancer Research Group

You may qualify if…

✓ Patient must be \>= 18 years of age at the time of registration
✓ Patient must have been between the ages of 15-39 at the time of their first primary cancer diagnosis of Hodgkin lymphoma or non-Hodgkin lymphoma (NHL)
✓ Patient must have completed therapy (with a complete response, per clinician determination) at the time of registration
✓ Patients last date of prior systemic therapy for first primary diagnosis for Hodgkin lymphoma or non-Hodgkin lymphoma must have been within one year prior to registration
✓ NOTE: Systemic therapy refers to all anti-cancer therapy, including but not limited to chemotherapy, intravenous (IV) or oral targeted medications, or radiation, and administered via a clinical trial or standard approach
✓ Patient must have an Eastern Cooperative Oncology Group (ECOG) Performance Status of 0-3
✓ Patient must be English speaking in order to be able to complete the required QOL forms on this study
✓ NOTE: Sites cannot translate the associated QOL forms